SCHEMBL4455027

SCHEMBL4455027

CCc1cccc(C2=CCC(OC)(C(C)=O)C=C2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL2 P10415 1/20 0.39
PTGS2 P35354 1/20 0.36
CYP4F2 P78329 1/20 0.34
CYP4A11 Q02928 1/20 0.34
THRA P10827 1/20 0.33
THRB P10828 1/20 0.33
NISCH Q9Y2I1 1/20 0.33
DHFR P00374 2/20 0.32
MME P08473 1/20 0.32
POLQ O75417 1/20 0.32
NOTUM Q6P988 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.31
IDO1 P14902 1/20 0.31
CHRM3 P20309 1/20 0.31
TAS1R3 Q7RTX0 1/20 0.31
TAS1R1 Q7RTX1 1/20 0.31
TAS1R2 Q8TE23 1/20 0.31
LMNA P02545 1/20 0.31
HTT P42858 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6903846 0.82 SMN1; SMN2 (0.32) SMN1; SMN2
SCHEMBL4453136 0.77 BCL2 (0.36) BCL2PTGS2CYP4F2CYP4A11THRA
SCHEMBL29154634 0.70 GAA (0.33) SMN1; SMN2
SCHEMBL5984481 0.70 MEN1 (0.37) SMN1; SMN2IDO1LMNAHTTKMT2A
SCHEMBL9487256 0.70 ALDH1A1 (0.33) THRBMME
SCHEMBL30884655 0.68 ALDH1A1 (0.31) LMNA
SCHEMBL28667025 0.65 RET (0.33) LMNAKMT2A
SCHEMBL18723855 0.65 CXCR3 (0.30)
SCHEMBL4186206 0.62 CHRM2 (0.39) CHRM3LMNAKMT2A
SCHEMBL5828435 0.62 CHRM2 (0.39) CHRM3LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2013176-A2 DIARYL COMPOUNDS AS NON-STEROIDAL INHIBITORS OF 17-BETA HYDROXYSTEROID DEHYDROGENASE AND/OR STEROID SULPHATASE FOR THE TREATMENT OF OESTROGEN-RELATED DISEASES SUCH AS HORMONE DEPENDENT BREAST CANCER Sterix Limited (GB) 2009-01-14 EP disclosed
WO-2007096647-A2 DIARYL COMPOUNDS AS NON-STEROIDAL INHIBITORS OF 17-BETA HYDROXYSTEROID DEHYDROGENASE AND/OR STEROID SULPHATASE FOR THE TREATMENT OF OESTROGEN-RELATED DISEASES SUCH AS HORMONE DEPENDENT BREAST CANCER STERIX LIMITED (GB) 2007-08-30 WO disclosed